My previous background is in Medicine and health science, having worked as a doctor in acute and general medicine, as well as in clinical virtual reality learning opportunities for a number of years. During my years as a clinician I became increasing interested in patient care for those experiencing substance use, particularly for those experiencing problematic use and wanted to explore how improvements in care could be made. In light of this I have embarked upon my PhD, exploring ways of providing take home naloxone from hospital settings to people who use drugs.
Addiction and substance use, harm reduction, overdose, opioid use and take home naloxone provision and use.
Review
Masterton W, Falzon D, Burton G, Carver H, Wallace B, Aston EV, Sumnall H, Measham F, Gittins R, Craik V, Schofield J, Little S & Parkes T (2022) A Realist Review of How Community-Based Drug Checking Services Could Be Designed and Implemented to Promote Engagement of People Who Use Drugs. International Journal of Environmental Research and Public Health, 19 (19), Art. No.: 11960. https://doi.org/10.3390/ijerph191911960
Article
Burton G, McAuley A, Schofield J, Yeung A, Matheson C & Parkes T (2021) A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage. International Journal of Drug Policy, 96, Art. No.: 103298. https://doi.org/10.1016/j.drugpo.2021.103298
Website Content
Overdose prevention after hospital discharge – broadening take-home naloxone provision
Burton G (2021) Overdose prevention after hospital discharge – broadening take-home naloxone provision. Scottish Drug Deaths Taskforce [Blog post] 10.05.2021. https://drugdeathstaskforce.scot/our-work/targeted-distribution-of-naloxone/overdose-prevention-after-hospital-discharge-broadening-take-home-naloxone-provision/
